Palisade bio selects dose for upcoming phase 1 clinical study of pali-2108 for ulcerative colitis

– phase 1 human clinical study of pali-2108 for the treatment of ulcerative colitis (uc) on track to commence before year end
PALI Ratings Summary
PALI Quant Ranking